Skip to main content
Fig. 4 | Journal of Experimental & Clinical Cancer Research

Fig. 4

From: miR-22/KAT6B axis is a chemotherapeutic determiner via regulation of PI3k-Akt-NF-kB pathway in tongue squamous cell carcinoma

Fig. 4

KAT6B inversely correlates with miR-22 and correlated to poor DFS progression in tongue cancer patients. a, Expression levels of KAT6B in 56 tongue cancer patients who received cDDP based regimen neoadjuvant chemotherapy were analyzed by quantitative PCR. GAPDH was used as an internal control. Data were shown as mean ± SD. b, Spearman rank test of 56 tongue cancer patients was used for depicting the correlation between KAT6B and miR-22. c, High KAT6B level correlated to poor DFS in tongue cancer patients received chemotherapy

Back to article page